Reference
Health Canada. Atypical hemolytic reactions following exposure to gemtuzumab ozogamicin Health Product InfoWatch : 3-4, Dec 2021. Available from: URL: https://www.canada.ca/content/dam/hc-sc/documents/services/drugs-health-products/medeffect-canada/health-product-infowatch/december-2021/december-2021.pdf
Rights and permissions
About this article
Cite this article
Atypical haemolytic reactions after gemtuzumab ozogamicin. Reactions Weekly 1888, 1 (2022). https://doi.org/10.1007/s40278-022-08343-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-08343-9